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Purpose: The nitric oxide precursor, L-arginine, has been shown to have a salutary effect 
on ischemia and reperfusion injury in skeletal muscle, skin, and intestines. Because 
L-arginine also increases renal blood flow, glomerular filtration, and urine flow in 
experimental nimals with normal renal function, we postulated that L-arginine may also 
improve renal function after renal ischemic injury. 
Methods: Eighteen adult New Zealand white rabbits weighing 3 to 3.5 kg were subjected 
to bilateral normothermic renal ischemia by clamping both renal pedicles for 1 hour 
followed by 2 hours of reperfusion. The animals were randomized into three groups: 
group I (control, n = 6) received no additional treatment; group I I  (pretreatment,  = 6) 
received systemic intravenous L-arginine at 150 mg/kg over 20 minutes before induction 
ofischemia; group I I I  (posttreatment,  = 6) received systemic intravenous L-arginine at 
150 mg/kg over 20 minutes from the onset ofreperfusion. Urine flow, creatinine clearance 
(Cc~ , fractional excretion of sodium (FENa), and renal failure index (RFI) were 
calculated before ischemia nd 2 hours after eperfusion, by use of standard formulas. The 
changes of the various renal parameters were compared among the three groups. 
Results: Bilateral normothermic renal ischemia for 1 hour produced a significant 
deterioration ofglomentlar filtration as evidenced by a Cow decrease from 11.1 + 1.8 to 
2.49 + 0.9 ml/min (p < 0.01), FENa increase from 2.9% + 1.0% to 20.8% + 1.5% 
(p < 0.01)andRFIincreasefrom4.0 -+ 1.3to28.8 - 2.6 (p < 0.01).Pretreatmentwith 
L-arginine (group II) minimized the deleterious effects caused by ischemia on glomerular 
filtration (CcF " of 2.49 + 0.9 ml/min in group I vs 4.95 + 2.5 ml/min in group II, 
p < 0.05) and tubular function (FENa of 20.8% + 1.5% in group I vs 13.0% + 5.6% in 
group I I  and RFI of 28.8 +- 2.6 in group I vs 18.6 + 8.0 in group II, p < 0.05). Infusion 
of L-arginine at the onset of reperfusion (group I I I)  produced asignificant diuretic effect 
(urine flow from 32.6 + 13.4 ml/hr in group I to 63.3 + 18.8 ml/hr in group I I I ,  
p < 0.05) and also minimized glomerular damage (Cow from 2.49 - 0.9 ml/min in group 
I to 4.80 + 1.2 ml/min in group I I I ,p  < 0.05); however, no beneficial effect was observed 
on tubular function. 
Conclusion: Induction of nitric oxide production by systemic L-arginine infusion can best 
preserve glomerular and tubular function in the ischemic/reperfused ki ney when given 
before the ischemic insult. (J VASC SURG 1995;21:453-9.) 
Renal ischemia followed by reperfusion occurs as 
a result of several clinical situations, most notably, 
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after suprarenal aortic crossclamping for aortic or 
renal arterial reconstructions. The renal injury caused 
by this ischemia/reperfusion (I/R) sequence is mani- 
fest as a combination of  glomerular and tubular 
damage resulting in renal insufficiency or overt 
kidney failure with its accompanying increased mor- 
bidity and mortality rates.1 Any attempts at protec- 
tion of renal fimction from I /R  injury must be 
directed toward either the prevention of  the cascade 
of cellular events incited by the I /R sequence or 
toward an amplification of endogenous cytoprotec- 
tive mechanisms that are active during I/R. 
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Nitric oxide has recently been demonstrated as a 
cytoprotective agent during ischemia nd reperfusion 
in several organ systems. This protective ffect may 
be a consequence of its activity as a direct vasodilator, 
an antiadhesion molecule (preventing activation of 
platelets and leukocytes) or an antioxidant molecule 
(inactivating superoxide species). 27 The L-argi- 
nine/nitric oxide pathway provides apotentially use- 
ful therapeutic tool for the induction of nitric oxide 
for cytoprotective purposes. 81° In experimental ani- 
mals, nitric oxide has been found to cause renal effer- 
ent arteriolar vasodilation, diuresis, natriuresis, and 
an increase in glomerular filtration. 9,11 Its functions 
during renal ischemia nd reperfusion have yet to be 
well defined. 
We postulated that enhancing nitric oxide pro- 
duction, by the administration f L-arginine, would 
help to protect the kidney from the deleterious effects 
of acute ischemia and reperfusion. To test this 
hypothesis we have studied the response of several 
standard renal functional parameters to infusions of 
L-arginine in an animal model of acute renal ischemia 
and reperfusion i jury. 
MATERIAL AND METHODS 
Anesthesia nd surgical preparation 
Eighteen New Zealand white rabbits (3 to 3.5 kg) 
were used in these xperiments, which complied with 
the Guide for the Care of Laboratory Animals (NIH 
Publication No. 86-23, revised 1985). Acepromazine 
(0.5 to i mg/kg) was given intramuscularly to the 
experimental nimals 15 to 30 minutes before the 
induction of general anesthesia.12 A 4 gauge 3/4 inch 
angiocath was used to start an intravenous line in the 
marginal ear vein. This was used for the infusion of 
replacement fluids throughout the surgical procedure 
at a rate of 10 to 15 cc/kg. Additional intravenous 
lines were started for drug infusions. Anesthesia was 
induced by intramuscular injection of xylazine (2 to 
5 mg/kg) and ketamine (35 to 40 mg/kg). All animals 
were monitored with rectal temperature probe, and 
the core temperature was maintained at37 ° C by use 
of a heating blanket. An arterial line was placed for 
blood pressure monitoring and blood sampling. 
Arterial blood gases were monitored periodically to 
maintain apH of 7.35 to 7.45. A Foley-type urinary 
catheter (8F) was inserted for accurate urinary 
volume determinations. Repeated oses of ketamine 
(10 to 15 mg/kg) and xylazine (1.0 mg/kg) were 
given throughout the procedure to maintain an 
adequate plane of anesthesia. 
The animals were explored through a midline 
laparotomy incision, and the renal pedicles were 
identified bilaterally. Normothermic ischemia was 
accomplished by the simultaneous placement of 
noncrushing vascular clamps across the vascular 
pedicles for 1 hour. The ureters were not occluded 
during this maneuver. Normothermic reperfusion 
occurred at the removal of the renal vascular pedicle 
clamps. Before the I/R sequence, a priming dose of 
creatinine, 50 mg/kg, was given followed by a 
constant infusion of 1 mg/kg/min. After 20 minutes 
of equilibration time, the first of three clearance 
periods (20 minutes each) was started, during which 
urine was collected for the determination f creati- 
nine and sodium and volume. At the midpoint of 
each period, blood samples were obtained for so- 
dium, creatinine, and urea nitrogen determinations. 
After i hour of warm ischemia and 2 hours of 
reperfusion, another three clearance periods (20 
minutes each) were performed in an identical man- 
ner. At the end of the procedures, both kidneys were 
taken for histologic examination, and the animals 
were killed with intravenous overdose of sodium 
pentobarbital (Nembutal) 50 mg/kg and 40 mEq 
KC1.13 
Experimental protocol 
The animals were blindly randomized into three 
groups. Group I served as a control group (under- 
going IR but no drug treatment), group II received 
L-arginine before ischemia (pretreatment) and group 
III received L-arginine after ischemia t the onset of 
reperfusion (post-treatment). 
Group I: Control group. Six rabbits were 
prepared as described previously. These animals 
received only systemic intravenous fluid at 10 
cc/kg/hr. Three creatinine clearance periods werc 
determined before ischemia nd at the end of 2 hours 
of reperfusion. Both kidneys were removed for 
histologic examination, and the animals were killed at 
the end of the procedure as described previously. 
Group II: L-arginine pretreatment. After sur- 
gical preparation, three 20-minute control creatinlne 
clearances were determined in six rabbits. The rabbits 
were then given systemic ntravenous L-arginine (150 
mg/kg) over 20 minutes. After 1 hour of warm isch- 
emia and 2 hours of reperfusion, another three creat- 
inine clearances were determined, kidneys were re- 
moved for histologic evaluation, and the animals 
were killed. 
Group III: L-arginine posttreatment. After 1 
hour of bilateral warm renal ischemia, six rab- 
bits received systemic intravenous L-arginine (150 
mg/kg) over 20 minutes, and the renal pedicle clamps 
were removed, initiating the reperfusion phase. 
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Fig. 1. Effect of 1 hour of normothermic renal ischemia followed by 2 hours of reperfusion 
on UF, Ccr, FENa, and RFI. 
Three 20-minute creatinine clearance periods were 
determined before ischemia nd 2 hours after reper- 
fusion. The animals were similarly killed after kidney 
removal for histologic examination. 
During each timed clearance period, urine vol- 
ume and the creatinine concentration i urine and 
plasma were simultaneously determined for creati- 
nine clearance calculations as an estimation of the 
glomerular filtration rate (GFR). Sodium concentra- 
tions were also simultaneously determined in the 
blood and urine for the calculation of sodium 
excretion, fractional excretion of sodium (FENa), 
and renal failure index (RFI).14 All data are presented 
as means + standard eviation and were analyzed for 
statistical significance by the Student's t test in the 
same group and analysis of variance among different 
groups. 
RESULTS 
During the ischemic interval all animals in all 
groups were anuric, confirming the adequacy of the 
renal vascular pedicle occlusion. The 2-hour reperfu- 
sion period heralded an early return of urine produc- 
tion in all groups, similarly confirming vascular 
reflow through the temporarily occluded renal vas- 
cular pedicles. Bilateral normothermic renal ischemia 
for 1 hour followed by 2 hours of reperfusion 
without any drug treatment served to test he severity 
of this model of renal I/R and to compare with the 
parameters among the treated groups. Fig. 1 sum- 
marizes the effects of this injury sequence on the urine 
flow (UF), creatinine clearance (CcR), FENa, and 
RFI. This sequence of renal I/R produced acute 
changes in these renal functional parameters consis- 
tent with acute kidney failure. Both the glomerular 
and tubular functions were acutely impaired, as 
demonstrated by a significant decrease in the GFR, 
increase in the FENa and increase in the RFI. A 
moderate diuresis was also noted in this control 
group, although these data did not achieve statistical 
significance. Infusion of L-arginine before the period 
of ischemia served both to confirm the effects of 
L-arginine on normal renal function and to determine 
whether L-arginine pretreatment would prevent he 
deleterious effects of 1 hour of renal ischemia 
followed by 2 hours ofreperfusion seen in the control 
group. Fig. 2 summarizes the effect of L-arginine 
pretreatment on normal renal function in this rabbit 
model. L-Arginine infusion alone produced asignif- 
icant increase in CcR from 11.3 __ 3.7 to 21.5 __ 6.3 
ml/min (p < 0.01) concomitant with a significant 
increase in UF from 22.7 _+ 3.6 to 51.6 _+ I0.8 
ml/hr (p < 0.01). L-Arginine did not significantly 
affect he already normal parameters ofFENa or RFI. 
Renal functional parameters calculated after the 
2-hour reperfilsion period are summarized in Fig. 3 
with comparisons between the untreated control 
animals' 2-hour reperfusion data and those either 
pretreated orposttreated with L-arginine. These data 
show that L-arginine infusion before ischemia pro- 
duced a significant increase in the postreperfusion 
GFR as demonstrated by a Cce " increase from 
2.5 _+ 0.9 to 5.0 +- 2.5 ml/min (p < 0.05). A sig- 
nificant diuresis was not noted to accompany this 
increase in CcR in the reperfusion period. Pretreat- 
ment with L-arginine also effected a significant 
decrease in the FENa from 20.8% _+ 1.5% to 
13.0% _ 5,6% (p < 0.05) and a decrease inthe RFI 
from 28.8 + 2.6 to 18.6 + 8.0 (p < 0.05). A sig- 
nificant diuretic effect was observed in the L-arginine 
posttreated animals, with UF increasing from 
32.7 + 13.4 to 63.3 + 18.8 ml/hr (p < 0.01) and 
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Fig. 3. Effect of L-arginine pretreatment and posttreatment onUF, Ccr, FENa, and RFI in 
ischemic/reperfused kidney. 
an increase in the GFR, as evidenced by a Ccp `
increase from 2.5 _+ 0.9 to 4.8 _+ 1.2 ml/min 
(p < 0.05). FENa and RFI were not, however, 
significantly affected by the infusion of L-arginine at 
the onset of reperfusion as was observed in the 
pretreatment group. 
DISCUSSION 
This model of acute bilateral renal I/R simulates 
the events that occur during acute occlusion of the 
suprarenal ortic segment. The severity of the resul- 
tant renal injury is evidenced by the dramatic 
reduction in the postreperfusion Ccp,, increase in the 
fractional excretion of sodium, and increase in the 
RFI. The infusion of L-arginine as a stimulator of 
endogenous nitric oxide production has been con- 
firmed as a potent diuretic in the nonischemic kidney 
in this rabbit model. This effect may be related to the 
direct vasi~dilatory effect of nitric oxide on the renal 
efferent arteriole with resultant increased glomerular 
blood flow. Eisner and Mtmtze is demonstrated 
increased efferent arteriolar vasoconstriction with the 
L-arginine antagonist L-NNA without significant 
decrease in the GFR in the normal kidney. Also, 
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Yuldmura nd Yamashita 16 have demonstrated recov- 
ery of depressed renal blood flow induced with 
L-NNA by treatment with direct intraarterial 
L-arginine infusion. E1 Sayed et al?l demonstrated 
reductions inrenal perfusion, GFR, and UF rate with 
arginine depletion that were completely reversed by 
arginine reinfusion. This study expands the known 
actions of L-arginine infusion to include a similar 
diuretic effect in the ischemic/reperfused kidney. This 
diuretic effect was noted only in those animals who 
received L-arginine infusion at the onset of renal 
reperfusion. Those animals who received Lrarginine 
infusion before the ischemic insult did not demon- 
strate a significant diuresis at reperfusion. The 
temporal relationship of L-arginine infusion to in- 
duction of nitric oxide production i this model is not 
entirely clear. Also, the short half-life of nitric oxide 
may have impacted on the differences seen in diuretic 
effect between the pretreated and post-treated ani- 
mals. If nitric oxide were induced in the ischemic 
period, the effects of efferent arteriolar vasodilation 
and increased renal blood flow might not be apparent 
in the reperfusion i terval. Production of nitric oxide 
in the time period immediately preceding reperfusion 
did indeed produce significant diuresis, the beneficial 
effect of which is refuted by the other enal functional 
parameters measured. Despite these differences, 
both pretreatment and posttreatment groups dem- 
onstrated a doubling of the Ccv "compared with the 
untreated group. The fractional excretion of sodium, 
a parameter more closely associated with renal 
tubular function, was found to be significantly 
improved in the animals pretreated with L-arginine; 
however, those animals treated at the onset of 
reperfusion did not demonstrate this effect. The RFI, 
used as a more specific parameter of intrinsic renal 
impairment, similarly was protected in the pretreated 
group but unaffected in the posttreatment animals. 
This combination of diuresis, increased Ccv " but no 
effect on FENa or RFI in the posttreatrnent group, 
suggests some glomerular protection without effect 
on the severe tubular dysfunction caused by the I/R 
sequence. In contrast, he pretreatment group dem- 
onstrating improvement in the FENa and Ccv "
suggests both protection of glomerular and tubular 
function. Apparently, the diuretic effect of posttreat- 
ment was not beneficial to overall renal function. 
Pretreatment, however, which did not cause signifi- 
cant diuresis, better preserved renal function. 
Cellular and organ damage caused by ischemia 
and reperfusion has been studied in several major 
organ systems. It is becoming apparent that the cause 
of this injury is multifactorial. The production of 
oxygen-derived free radicals, the activation of leuko- 
cytes and platelets, the buildup of cellular metabo- 
rites, the elaboration ofvarious cytokines, and the "no 
reflow" phenomenon all play a role in the ultimate 
organ injury observed. 7,17-21 Nitric oxide has been 
shown to antagonize the activity of the superoxide 
species, as well as to prevent the activation of 
leukocytes, by preventing adhesion. Its activity in the 
prevention of the "no reflow" phenomenon is not 
clearly delineated, although its vasodilatory effect is 
likely beneficial in preventing "no reflow"i With these 
far-reaching activities, it is not unreasonable that 
endogenous stimulation of nitric oxide production, 
at some specific time during the initiation of this 
cascade of events, would have an overall beneficial 
effect on the prevention of organ damage. Our study 
indicates that the early ischemic period is the most 
efficient arget for this purpose in the case of renal 
I/R. Although we have shown a benefit to the 
infusion of L-arginine on the acute renal impairment 
resultant from I/R, the long-term effect of this 
treatment remains unclear. Furthermore, there is not 
strong evidence to elucidate the specific mechanism 
through which this protective ffect is active. 
This work has potential clinical implications in 
the field of suprarenal ortic surgery, as well as in 
renal reconstructive and ex vivo kidney surgery. If the 
infusion of L-arginine shows to have lasting effects on 
the protection of renal function in I/R, its implemen- 
tation into clinical use will be facilitated by the 
growing experience with this amino acid in other 
medical therapeutics. 22-24 
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DISCUSSION 
Dr. Anton N. Sidawy (Washington, D.C.). This study 
attempts to evaluate a possible role for L-arginine in 
enhancing renal function after an ischemic reperfusion 
injury. L-Arginine is metabolized in vivo to nitric oxide. 
Nitric oxide has a number of biologic activities. These 
include relaxation of vascular smooth muscle, reduced 
platelet aggregation, reduced adherence of blood cells to 
the vas~lar endothelium, and a possible cytoprotective 
effect by combining with free radicals. Nitric oxide, given 
as the free gas in aqueous olution and also as acidified 
sodium nitrite, has been shown to have a beneficial effect 
in splanchnic vascular occlusion shock. New nitric oxide 
donor drugs are being developed in the hope of reducing 
damage after stroke or myocardial infarction. One of these, 
C87-3754, has been shown to lead to improved survival 
after mesenteric artery occlusion in an animal model. 
L-Arginine, the natural precursor of nitric oxide, can, under 
some circumstances, lead to enhanced nitric oxide produc- 
tion. It seems reasonable to hypothesize that exogenous 
L-arginine may be of benefit in renal ischemic episodes. 
This study uses a rabbit model to assess the value of 
administering L-arginine in renal ischemia. Three study 
groups were examined. One received L-arginine immedi- 
ately before ischemia was induced, one received it imme- 
diately after ischemia, and one group received no 
L-arginine. Parameters of glomerular and tubular function 
were measured and compared by use of appropriate 
statistical methods. It was concluded that L-arginine given 
immediately after ischemia reduced glomerular damage, 
led to increased diuresis, but did not protect against tubular 
damage. L-Arginine given before ischemia additionally 
gave some protection against tubular damage. The conclu- 
sions seem valid given the data shown. 
The magnitude of the benefit appears relatively small 
and was assessed after a short time interval. Do the authors 
believe that a significant benefit would still be present after 
longer time periods? 
Do the authors attribute all benefits of L-arginine to 
increased nitric oxide production? Did they consider 
making any attempt to detect his for example by measur- 
ing urinary nitrite? 
Did the authors consider using one of the new nitrite 
oxide donor drugs (the sydonimines) todetermine whether 
they had any benefit? 
Dr. Robert  M. Pollina. The absolute magnitude of the 
results that we have seen in the study are not large. How- 
ever, we saw an increase in the Ccr of the treated animals of 
approximately double that of the control animals. Looking 
at the absolute numbers, the Ccr from the normal state 
compared with the control animals was far more than half. 
If  we look at the severity of this model, we see that this 
model may be more severe ven than the models of human 
renal ischemia reperfusion. It is likely that a comparable 
model would be a complete cross-clamping of the renal 
artery for several hours, which would likely result in no 
return of renal function. The benefit that we saw with 
L-arginine was only in the early period after the operative 
procedure and may or may not carry to longer term peri- 
ods. We did not examine it specifically, although we are 
studying animals for a longer term in a similar model. The 
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benefits that we saw may be a result of L-arginine alone. We 
did not use any other specific nitric oxide donors, although 
there is work in our laboratory on the use of nipride to try 
to induce nitric oxide production in a skeletal muscle 
ischemia reperfusion model. 
Measurements ofnitric oxide production include direct 
measurement with the recent introduction of specific nitric 
oxide meter and the measurement of urinary nitrides. The 
urinary nitrites were not measured in this model. 
Dr. Harry L. Bush (New York, N.Y.). It sounds like 
you are not sure about how much of this is vasodilatory 
directly and how much is related to interrupting the 
reperfusion effects. Do you have a sense of the timing of the 
action of L-arginine, that is to say the duration from the 
time you give it to the onset of relaxation of the arteries? 
Dr. Pollina. From this study it seems apparent that, 
because the most protection was when L-arginine was given 
early in the I /R sequence, the induction of its effects occur 
within 1 hour. Similarly I believe that nitric oxide may be 
a double-edged sword. As we have seen in some of the work 
done on septic models, the production of nitric oxide is 
believed to be deleterious to the overall effects on the 
organism. It is indeed possible that giving a nitric oxide 
inducer at the onset of reperfusion might mimic these 
septic effects, whereas giving it early in the sequence of 
I /R might actually set up a protective or readying effect 
of the kidney for the I /R sequence. We are studying 
whether it is more a vasodilatory or an antioxidant 
molecule with a study involved with superoxide dismutase 
and N-monomethyl-L-arginine with this same model. 
